Illumina adds pan-cancer CDx indication to TruSight Oncology test
The new CDx pan-cancer indication will allow the identification of cancer patients with solid tumours that have neurotrophic…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 May 22
The new CDx pan-cancer indication will allow the identification of cancer patients with solid tumours that have neurotrophic…
25 May 22
The AI platform allows to triage the patients faster and align the care teams rapidly by detecting the…
25 May 22
If authorised, the algorithm will be available as Software as a Medical Device (SaMD)
25 May 22
Technology will enable safe and efficacious delivery of Pancryos' Stem Cell Derived therapy for treatment of Type 1…
25 May 22
Invenio Imaging is a medical device start-up based in Santa Clara, CA dedicated to advancing the care of…
25 May 22
Aidoc broadens its X-ray AI offering with Gleamer’s BoneView solution, empowering health systems in the U.S. to address…
24 May 22
HistoSonics’ breakthrough liver therapy system Edison will leverage GE's LOGIQ E10 solution to enable real-time imaging guidance and…
24 May 22
HALO Prostate AI tool is installed using Indica Labs' CE-IVD marked HALO AP platform to deliver a completely…
24 May 22
The global trial, which is expected to run for 12 months, will enrol adults with suspected Coronary Artery…
24 May 22
The first clinical data of an implantable heart sensor with remote measurement capacity was presented at the prestigious…